Trademark: 97705569
Status Date
Wednesday, April 3, 2024
Filing Date
Tuesday, December 6, 2022
42 Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of inhibiting and reducing the pathological accumulation of extracellular matrix proteins; Research and development in the field of fibrosis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of inhibiting and reducing the pathological accumulation of extracellular matrix proteins
Apr 1, 2024
Approved For Pub - Principal Register
Feb 27, 2024
Teas/Email Correspondence Entered
Feb 27, 2024
Correspondence Received In Law Office
Feb 27, 2024
Teas Response To Office Action Received
Nov 29, 2023
Teas Change Of Correspondence Received
Nov 29, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 29, 2023
Teas Change Of Owner Address Received
Nov 29, 2023
Notification Of Non-Final Action E-Mailed
Nov 29, 2023
Non-Final Action E-Mailed
Nov 29, 2023
Non-Final Action Written
Oct 5, 2023
Teas/Email Correspondence Entered
Oct 5, 2023
Correspondence Received In Law Office
Oct 5, 2023
Teas Response To Office Action Received
Jul 10, 2023
Notification Of Non-Final Action E-Mailed
Jul 10, 2023
Non-Final Action E-Mailed
Jul 10, 2023
Non-Final Action Written
Jul 7, 2023
Assigned To Examiner
Jan 4, 2023
New Application Office Supplied Data Entered
Dec 9, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
